Comparison of the effects of colestipol hydrochloride and clofibrate on plasma lipids and lipoproteins in the treatment of hypercholesterolemia
- 1 April 1981
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 39 (1) , 35-43
- https://doi.org/10.1016/0021-9150(81)90086-1
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Cholestyramine Promotes Receptor-Mediated Low-Density-Lipoprotein CatabolismNew England Journal of Medicine, 1980
- Use of combined diet and colestipol in long-term (7--7 1/2 years) treatment of patients with type II hyperlipoproteinemia.Circulation, 1979
- Lecithin: Cholesterol acyl transfer rate and high density lipoproteins in plasma during dietary and clofibrate treatment of hypertriglyceridemic subjectsAtherosclerosis, 1978
- Treatment of hypertriglyceridemia with tibric acid and clofibrate — Cross-over studies, effects on lipoproteins and absence of post-drug reboundAtherosclerosis, 1978
- Colestipol hydrochloride in hypercholesterolemic patients—Effect on serum cholesterol and mortalityJournal of Chronic Diseases, 1978
- HDL cholesterol and other lipids in coronary heart disease. The cooperative lipoprotein phenotyping study.Circulation, 1977
- Pharmacokinetics of clofibrate in familial hypercholesterolemiaAtherosclerosis, 1977
- Cholesterol-lowering effect of colestipol hydrochloride given twice daily in hypercholesterolemic patientsAtherosclerosis, 1976
- Clofibrate in Type II HyperlipoproteinemiaActa Medica Scandinavica, 1976
- The Effects of Colestipol Resin and of Colestipol Plus Clofibrate on the Turnover of Plasma Cholesterol in ManJournal of Clinical Investigation, 1973